PlumX Metrics
Embed PlumX Metrics

Single-Cell Analysis Approaches in Cartilage Diseases Diagnosis and Therapies

Cartilage: From Biology to Biofabrication, Page: 67-95
2023
  • 0
    Citations
  • 0
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Book Chapter Description

Substantial evidence shows that major breakthrough toward cartilage therapeutic approaches is largely hampered by the low chondrocytes yield along with hetero-geneous off-target differentiation of cells during chondrogenesis. Therefore, a complete assessment of an individual cell is essential for exhaustive comprehen-sion of cell-to-cell variability. Nowadays, advances in stem cell biology have empowered the characterization of individual cells and biological mechanisms at the single-cell level. Single-cell analysis technologies represent the ultimate frontier of the transcriptomic landscape of thousands of single cells and revolutionize our understanding of cartilage tissue during normal homeostasis and diseases. Novel technologies like microfluidics and CRISPR/Cas9 technol-ogy are valuable for single-cell omics analysis due to their sensitivity and accuracy. In this chapter, we first present the single-cell profiling of mesenchymal stem cell heterogeneity. Next, we discuss the recent progress in single-cell genomics, epigenomics, and proteomics sequencing technologies. The single-cell multi-omics approaches associated with genomics, transcriptomics, proteo-mics, as well as epigenomics are reviewed to identify cellular subpopulations that drive the disease. We also address their applications in biomarker discovery, personalized medicine, and regenerative medicine with the focus on cartilage tissue.

Bibliographic Details

Mahsa Ghorbaninejad; Sara Farahi; Samaneh Hosseini; Mohamadreza Baghaban Eslaminejad; Farzaneh Mirzaeian; Fatemeh Khodabandehloo

Springer Science and Business Media LLC

Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know